Conexeu Sciences Income Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023
Selling, General & Admin	6.91	3.67	0.41	0.04
Depreciation & Amortization Expenses	0.03	0.02	-	-
Research & Development	0.33	0.27	0.24	-
Total Operating Expenses	7.27	3.96	0.64	0.04
Operating Income	-7.28	-3.96	-0.64	-0.04
Interest Income	0.1	0	-	-
Interest Expense	0	-0	-0.02	-
Other Non-Operating Income (Expense)	-0.02	0.04	0.19	0
Total Non-Operating Income (Expense)	0.08	0.04	0.17	0
Pretax Income	-7.2	-3.92	-0.47	-0.04
Net Income	-7.2	-3.92	-0.47	-0.04
Net Income to Common	-7.2	-3.92	-0.47	-0.04
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	18	13	7	2
Shares Outstanding (Diluted)	18	13	7	2
Shares Change	170.46%	87.74%	286.25%	-
EPS (Basic)	-0.43	-0.31	-0.07	-0.02
EPS (Diluted)	-0.43	-0.31	-0.07	-0.02
EPS Growth	-	-	-	-
Free Cash Flow	-4.38	-1.69	-0.23	-0
Free Cash Flow Growth	-	-	-	-
Free Cash Flow Per Share	-0.24	-0.13	-0.03	-0.00
EBITDA	-7.24	-3.95	-0.64	-0.04
EBIT	-7.28	-3.96	-0.64	-0.04

SEC Filings: 10-K · 10-Q